This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.
Explore a selection of our essential drug information below, or:
Identification
- Generic Name
- Ginsenosides
- DrugBank Accession Number
- DB14152
- Background
Dammarane type triterpene saponins based mainly on the aglycones, protopanaxadiol and protopanaxatriol.
- Type
- Small Molecule
- Groups
- Experimental
- Synonyms
- Ginseng root-neutral saponins
- Ginsenoside
- Neutral saponins of panax ginseng root
- External IDs
- BM-RE60
- KG 135
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Contraindications & Blackbox Warnings
Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Products
Drug product information from 10+ global regionsOur datasets provide approved product information including:dosage, form, labeller, route of administration, and marketing period.Access drug product information from over 10 global regions.- Over the Counter Products
Name Dosage Strength Route Labeller Marketing Start Marketing End Region Image K2LTS Telomerase Inhibitor Liquid 23 g/1001 Oral K2LT LAB, LLC 2024-06-20 Not applicable US 
Qwg-1000 Liquid 0.04 g/100mL Topical Institute of Quantum Bioscience 2022-11-20 Not applicable US Ruby Cell 4u Rg3 Pure Soap 0.7 g/100g Topical Dasan E&T Co., Ltd. 2014-12-01 2017-12-01 US - Mixture Products
Name Ingredients Dosage Route Labeller Marketing Start Marketing End Region Image Herbal Iron Brilliant Performance for Brightening and Wrinkle Free Ginsenosides (0.05 g/100mL) + Ginsenosides (0.05 g/100mL) + Ginsenosides (0.1 g/100mL) + Ginsenosides (0.1 g/100g) + Adenosine (0.04 g/100mL) + Adenosine (0.04 g/100mL) + Adenosine (0.04 g/100mL) + Adenosine (0.04 g/100g) Kit Topical Btgin Co.,Ltd 2017-03-27 Not applicable US Herbal Iron Brilliant Performance for Brightening and Wrinkle Free Ginsenosides (0.05 g/100mL) + Ginsenosides (0.05 g/100mL) + Ginsenosides (0.1 g/100mL) + Ginsenosides (0.1 g/100g) + Adenosine (0.04 g/100mL) + Adenosine (0.04 g/100mL) + Adenosine (0.04 g/100mL) + Adenosine (0.04 g/100g) Kit Topical Btgin Co.,Ltd 2017-03-27 Not applicable US Herbal Iron Brilliant Performance for Brightening and Wrinkle Free Ginsenosides (0.05 g/100mL) + Ginsenosides (0.05 g/100mL) + Ginsenosides (0.1 g/100mL) + Ginsenosides (0.1 g/100g) + Adenosine (0.04 g/100mL) + Adenosine (0.04 g/100mL) + Adenosine (0.04 g/100mL) + Adenosine (0.04 g/100g) Kit Topical Btgin Co.,Ltd 2017-03-27 Not applicable US Herbal Iron Brilliant Performance for Brightening and Wrinkle Free Ginsenosides (0.05 g/100mL) + Ginsenosides (0.05 g/100mL) + Ginsenosides (0.1 g/100mL) + Ginsenosides (0.1 g/100g) + Adenosine (0.04 g/100mL) + Adenosine (0.04 g/100mL) + Adenosine (0.04 g/100mL) + Adenosine (0.04 g/100g) Kit Topical Btgin Co.,Ltd 2017-03-27 Not applicable US HERBAL IRON Enriched Moisture Ginsenosides (0.05 g/100mL) + Adenosine (0.04 g/100mL) Emulsion Topical Btgin Co.,Ltd 2017-03-16 2017-03-27 US - Unapproved/Other Products
Name Ingredients Dosage Route Labeller Marketing Start Marketing End Region Image Herbal Iron Brilliant Performance for Brightening and Wrinkle Free Ginsenosides (0.05 g/100mL) + Ginsenosides (0.05 g/100mL) + Ginsenosides (0.1 g/100mL) + Ginsenosides (0.1 g/100g) + Adenosine (0.04 g/100mL) + Adenosine (0.04 g/100mL) + Adenosine (0.04 g/100mL) + Adenosine (0.04 g/100g) Kit Topical Btgin Co.,Ltd 2017-03-27 Not applicable US Herbal Iron Brilliant Performance for Brightening and Wrinkle Free Ginsenosides (0.05 g/100mL) + Ginsenosides (0.05 g/100mL) + Ginsenosides (0.1 g/100mL) + Ginsenosides (0.1 g/100g) + Adenosine (0.04 g/100mL) + Adenosine (0.04 g/100mL) + Adenosine (0.04 g/100mL) + Adenosine (0.04 g/100g) Kit Topical Btgin Co.,Ltd 2017-03-27 Not applicable US Herbal Iron Brilliant Performance for Brightening and Wrinkle Free Ginsenosides (0.05 g/100mL) + Ginsenosides (0.05 g/100mL) + Ginsenosides (0.1 g/100mL) + Ginsenosides (0.1 g/100g) + Adenosine (0.04 g/100mL) + Adenosine (0.04 g/100mL) + Adenosine (0.04 g/100mL) + Adenosine (0.04 g/100g) Kit Topical Btgin Co.,Ltd 2017-03-27 Not applicable US Herbal Iron Brilliant Performance for Brightening and Wrinkle Free Ginsenosides (0.05 g/100mL) + Ginsenosides (0.05 g/100mL) + Ginsenosides (0.1 g/100mL) + Ginsenosides (0.1 g/100g) + Adenosine (0.04 g/100mL) + Adenosine (0.04 g/100mL) + Adenosine (0.04 g/100mL) + Adenosine (0.04 g/100g) Kit Topical Btgin Co.,Ltd 2017-03-27 Not applicable US HERBAL IRON Enriched Moisture Ginsenosides (0.05 g/100mL) + Adenosine (0.04 g/100mL) Emulsion Topical Btgin Co.,Ltd 2017-03-16 2017-03-27 US
Categories
- Drug Categories
- Classification
- Not classified
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- 3K198YD54P
- CAS number
- 74749-74-9
References
- General References
- Not Available
- External Links
- ChemSpider
- 2342730
- 349656
- Wikipedia
- Ginsenoside
Clinical Trials
- Clinical Trials
Clinical Trial & Rare Diseases Add-on Data Package
Explore 4,000+ rare diseases, orphan drugs & condition pairs, clinical trial why stopped data, & more. Preview package Phase Status Purpose Conditions Count Start Date Why Stopped 100+ additional columns Unlock 175K+ rows when you subscribe.View sample data4 Completed Treatment Fatigue 1 somestatus stop reason just information to hide 2 Unknown Status Treatment Non-Small Cell Lung Cancer (NSCLC) 1 somestatus stop reason just information to hide Not Available Completed Not Available Acute Lung Injury/Acute Respiratory Distress Syndrome (ARDS) / Apoptosis / Immunosuppression / Neutrophils / Pathogenesis 1 somestatus stop reason just information to hide
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
Form Route Strength Kit Topical Emulsion Topical Liquid Topical Liquid Oral 23 g/1001 Liquid Topical 0.04 g/100mL Soap Topical 0.7 g/100g - Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Not Available
- Experimental Properties
- Not Available
- Predicted Properties
- Not Available
- Predicted ADMET Features
- Not Available
Spectra
- Mass Spec (NIST)
- Not Available
- Spectra
- Not Available
- Chromatographic Properties
Collision Cross Sections (CCS)
Not Available
Drug created at June 28, 2018 21:54 / Updated at July 12, 2024 11:44